News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CN SASAC Advocates to Accelerate Development of Central SOEs in the Biopharmaceutical Industry, Build National Team in Such Field
Tan Zuojun, Deputy Director of the State-owned Assets Supervision and Administration Commission (SASAC), recently attended the "Advanced Training Course on Biotechnology Indus...
Reset
Send
The window will close in 5 seconds
CN SASAC Advocates to Accelerate Development of Central SOEs in the Biopharmaceutical Industry, Build National Team in Such Field
Close
Recommend
109
Positive
173
Negative
58
 
SHORT SELL
 
STOCK INFO

Tan Zuojun, Deputy Director of the State-owned Assets Supervision and Administration Commission (SASAC), recently attended the "Advanced Training Course on Biotechnology Industry for Central State-owned Enterprises (SOEs)" and emphasized the need to accelerate the development of central SOEs in the biopharmaceutical industry. He stressed the importance of innovation-driven development, long-term development, and differentiated development.

It is crucial to precisely seize the key development directions and implementation paths for central SOEs and actively promote collaborative innovation with research institutes of the Chinese Academy of Sciences, he said. The aim is to expedite the formation of a national team in the biopharmaceutical field and promote high-quality development of the biopharmaceutical industry in the mainland.

Related NewsCLSA Lifts INNOVENT BIO (01801.HK) TP to $111.4 as Interim Results Beat

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.